Business Standard

Inheritance of ideas

In the midst of a raging debate over IP rights, the million-dollar question is who owns the vaccine? Is it the pharma firms, the country origin, the university they are developed in or the people?

Image
Premium

Arundhuti Dasgupta
Who owns the vaccine? The pharmaceutical companies and the countries they belong to or the universities that helped develop them? Or if one may dare ask, in the testosterone filled debate over intellectual property (IP) rights, the people?

Everyone agrees that the pandemic is humankind’s biggest challenge in over a century. Everyone also agrees that this pandemic does not respect borders and that no one is safe until everyone is vaccinated. But talk about an IP waiver so that people are vaccinated at the earliest, and the landscape swiftly turns into quicksand. Responses vary from a Gatesian rap on the knuckles
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in